Based on leading research at KTH and Uppsala University Zytox Therapeutics develops protein-based tumor targeting.
KTH Holding AB
Based on leading research at KTH and Uppsala University Zytox Therapeutics develops protein-based tumor targeting.
INVESTMENT
2021
WEBB
STATUS
Active
TAGS
Biotech, cancer, Pharma,